Keeper Security Delivers Structured Governance for Humans and AI Agents with New PAM Approval Workflows in KeeperPAM 
Integrated Quantum Launches $10K Kaggle Hackathon to ‘Pierce the VEIL’ 
CleanStart Launches Cleansight To Uncover Hidden Container Risk And Map Vulnerabilities To Trusted Replacement Images Core Assets Expands Blue Property to District Scale Land Package
VANCOUVER, BC / ACCESSWIRE / September 20, 2021 / Core Assets Corp., (“Core Assets” or…
Angle PLC Announces Parsortix Enables Gene Expression Analysis in mPCa
PARSORTIX SYSTEM ENABLES GENE EXPRESSION ANALYSIS IN METASTATIC PROSTATE CANCER PATIENTS Parsortix able to isolate…
TXA Project | A Hybrid Decentralized Exchange Offering Cross-Chain Settlement of Trades
HANOI, VIETNAM / ACCESSWIRE / September 20, 2021 / TXA App is a part of…
Tsodilo Resources Limited Announces Geotechnical Lab Results for the Preliminary Economic Assessment of Its Xaudum Iron Project in Botswana
TORONTO, ON / ACCESSWIRE / September 20, 2021 / Tsodilo Resources Limited (“Tsodilo” or the…
Evian Unveils 100% rPET Bottles Created by Loop Industries’ Innovative Recycling Technology
Committed to accelerating the development of innovative sustainable packaging solutions, evian achieves new milestone in…
Quadient Introduces iX-Series Mailing Systems and S.M.A.R.T. Essential Mail Management Software to the U.K. Market
User-focused iX-Series and S.M.A.R.T software is the most comprehensive, flexible and contemporary range of mailing…
The Media Art Festival Seasons of Media Arts is back again in the city!
17 September to 17 October, 2021 The urban Festival of Media Art Seasons of Media…
Becrypt wins Cyber/Defence Innovation Den
Government of Ontario and techUK promoting international Cyber collaboration London, UK: On 16th September, the…
Ventyx Biosciences Announces Key Appointments and Closing of $51.0 Million Series B Convertible Preferred Stock Financing Round
Drs. Sheila Gujrathi (Executive Chair), Jörn Drappa (Chief Medical Officer) and Luisa Salter-Cid (Chair of…
eureKARE announces participation of the European Innovation Council in the opening of the eureKAWARDS
eureKARE announces participation of the European Innovation Council in the opening of the eureKAWARDS Dr…
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune…
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune…
OSE Immunotherapeutics To Present Positive Results of Tedopi® Phase 3 Clinical Trial in Non-Small Cell Lung Cancer Patients in Secondary Resistance to Immune Checkpoint Inhibitors At the European Society for Medical Oncology (ESMO) Virtual Congress 2021
OSE Immunotherapeutics reminds the presentation on positive data of Tedopi® in non-small cell lung cancer today…
Santhera Secures CHF 45 Million in Funding and Announces Preliminary First Half-Year 2021 Financial Results
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN…
HUTCHMED Initiates a Japan Bridging Study to Support Surufatinib Registration for Advanced Neuroendocrine Tumors
Following surufatinib launch in China in January 2021; NDA acceptance by the U.S. FDA for…
Sorrento Announces an Independent Real-World Study That Reports Superior Sensitivity Results in Detecting COVID-19 Virus Infections in All-Comer General Population by COVISTIX as Compared to a Globally Leading Rapid Antigen Test
As a general screening for all-comers (i.e. COVID-19 symptomatic and asymptomatic populations), COVISTIX (n=783) has…
ESMO late-breaking data show Libtayo® (cemiplimab) and chemotherapy first-line treatment combination significantly improved overall survival in patients with advanced NSCLC
ESMO late-breaking data show Libtayo® (cemiplimab) and chemotherapy first-line treatment combination significantly improved overall survival…
Genmab and Seagen Present Interim Results From the innovaTV 205 Study for Tisotumab Vedotin Combination Therapy Treatment of Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2021
Media Release Tisotumab Vedotin in Combination with Carboplatin Showed Encouraging, Durable Anti-Tumor Activity as First-Line…
Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit…
Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19
SHANGHAI, China, Sept. 19, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a…